BACKGROUND: Medications for use as an adjunct to lifestyle modification therapy (LSM) for severe adolescent obesity are limited. Topiramate results in weight reduction in adults with obesity, but has not been studied in adolescents. OBJECTIVE: To examine the effect of topiramate plus LSM on body mass index (BMI) reduction in adolescents with severe obesity. METHODS: Data for this retrospective chart review were collected from patients attending a pediatric weight management program who were treated with LSM plus topiramate for 3 months minimum. Mean BMI percent change from baseline was evaluated using t-tests. RESULTS: Twenty-eight patients (mean age 15.2 ± 2.5 years, mean baseline BMI 46.2 ± 10.3 kg/m(2)) were identified for inclusion. The 6-month percent change in BMI was -4.9, 95% confidence interval (-7.1, -2.8), P < .001. CONCLUSIONS: Topiramate with concurrent LSM was associated with clinically meaningful BMI reduction in adolescents with severe obesity. Randomized controlled clinical trials examining efficacy and safety of topiramate for severe obesity in adolescents are needed.
BACKGROUND: Medications for use as an adjunct to lifestyle modification therapy (LSM) for severe adolescent obesity are limited. Topiramate results in weight reduction in adults with obesity, but has not been studied in adolescents. OBJECTIVE: To examine the effect of topiramate plus LSM on body mass index (BMI) reduction in adolescents with severe obesity. METHODS: Data for this retrospective chart review were collected from patients attending a pediatric weight management program who were treated with LSM plus topiramate for 3 months minimum. Mean BMI percent change from baseline was evaluated using t-tests. RESULTS: Twenty-eight patients (mean age 15.2 ± 2.5 years, mean baseline BMI 46.2 ± 10.3 kg/m(2)) were identified for inclusion. The 6-month percent change in BMI was -4.9, 95% confidence interval (-7.1, -2.8), P < .001. CONCLUSIONS:Topiramate with concurrent LSM was associated with clinically meaningful BMI reduction in adolescents with severe obesity. Randomized controlled clinical trials examining efficacy and safety of topiramate for severe obesity in adolescents are needed.
Authors: Paul W Franks; Robert L Hanson; William C Knowler; Maurice L Sievers; Peter H Bennett; Helen C Looker Journal: N Engl J Med Date: 2010-02-11 Impact factor: 91.245
Authors: Arne Astrup; Ian Caterson; Pierre Zelissen; Bernard Guy-Grand; Michele Carruba; Brian Levy; Xiang Sun; Martin Fitchet Journal: Obes Res Date: 2004-10
Authors: Deirdre C Kelleher; Chaya T Merrill; Linda T Cottrell; Evan P Nadler; Randall S Burd Journal: JAMA Pediatr Date: 2013-02 Impact factor: 16.193
Authors: Melissa A Kalarchian; Michele D Levine; Silva A Arslanian; Linda J Ewing; Patricia R Houck; Yu Cheng; Rebecca M Ringham; Carrie A Sheets; Marsha D Marcus Journal: Pediatrics Date: 2009-09-28 Impact factor: 7.124
Authors: Paul W Franks; Robert L Hanson; William C Knowler; Carol Moffett; Gleebah Enos; Aniello M Infante; Jonathan Krakoff; Helen C Looker Journal: Diabetes Date: 2007-08-24 Impact factor: 9.461
Authors: Claudia K Fox; Alexander M Kaizer; Kyle D Rudser; Brandon M Nathan; Amy C Gross; Muna Sunni; M Jennifer Abuzzahab; Betsy L Schwartz; Seema Kumar; Anna Petryk; Charles J Billington; Justin R Ryder; Aaron S Kelly Journal: Obesity (Silver Spring) Date: 2016-11-03 Impact factor: 5.002
Authors: Chika Vera Anekwe; Michael G Knight; Sujatha Seetharaman; Wesley P Dutton; Shradha M Chhabria; Fatima Cody Stanford Journal: Curr Treat Options Gastroenterol Date: 2021-07-16
Authors: Christine B San Giovanni; Brooke Sweeney; Joseph A Skelton; Megan M Kelsey; Aaron S Kelly Journal: J Clin Endocrinol Metab Date: 2021-06-16 Impact factor: 5.958
Authors: Lucy D Mastrandrea; Louise Witten; Kristin C Carlsson Petri; Paula M Hale; Hanna K Hedman; Robert A Riesenberg Journal: Pediatr Obes Date: 2019-01-17 Impact factor: 4.000
Authors: Gitanjali Srivastava; Claudia K Fox; Aaron S Kelly; Ania M Jastreboff; Allen F Browne; Nancy T Browne; Janey S A Pratt; Christopher Bolling; Marc P Michalsky; Stephen Cook; Carine M Lenders; Caroline M Apovian Journal: Obesity (Silver Spring) Date: 2019-02 Impact factor: 5.002
Authors: Chance S Friesen; Chelsea Hosey-Cojocari; Sherwin S Chan; Iván L Csanaky; Jonathan B Wagner; Brooke R Sweeney; Alec Friesen; Jason D Fraser; Valentina Shakhnovich Journal: Front Endocrinol (Lausanne) Date: 2021-04-13 Impact factor: 5.555